OCUL filings
Corporate insider profile
Jeffrey S. Heier Filing Activity
Latest reported as Chief Scientific Officer of OCULAR THERAPEUTIX, INC (OCUL).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$24,747.60
- Latest transaction
- May 26, 2026
Affiliated corporations
Reported company relationships
Transaction history
